BOOSTRIX-POLIO
BOOSTRIX-POLIO
Approved
DIN Number
02312557
Drug Class
Human
Market Date
Oct 22, 2010
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02312557
AIG Number0852468001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07CA02 DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (8)
DIPHTHERIA TOXOID ADSORBEDActive
Strength: 2.5 LF / 0.5 ML
Monograph: DIPHTHERIA TOXOID ADSORBED
FILAMENTOUS HAEMAGGLUTININ ADSORBEDActive
Strength: 8 MCG / 0.5 ML
Monograph: FILAMENTOUS HAEMAGGLUTININ ADSORBED
INACTIVATED POLIOVIRUS TYPE IActive
Strength: 40 D / 0.5 ML
Monograph: INACTIVATED POLIOVIRUS TYPE I
INACTIVATED POLIOVIRUS TYPE IIActive
Strength: 8 D / 0.5 ML
Monograph: INACTIVATED POLIOVIRUS TYPE II
INACTIVATED POLIOVIRUS TYPE IIIActive
Strength: 32 D / 0.5 ML
Monograph: INACTIVATED POLIOVIRUS TYPE III
PERTACTIN ADSORBEDActive
Strength: 2.5 MCG / 0.5 ML
Monograph: PERTACTIN ADSORBED
PERTUSSIS TOXOID ADSORBEDActive
Strength: 8 MCG / 0.5 ML
Monograph: PERTUSSIS TOXOID ADSORBED
TETANUS TOXOID ADSORBEDActive
Strength: 5.0 LF / 0.5 ML
Monograph: TETANUS TOXOID ADSORBED